WHO ICTRP trial

Study of alterations in the CYP2C19 gene and platelet activity in patients…

RBR-6n87rs · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting

Key facts

Trial ID RBR-6n87rs
Public title Study of alterations in the CYP2C19 gene and platelet activity in patients submitted to coronary angioplasty
Scientific title Study of CYP2C19, ABCB1 and PON1 polymorphism in patients submitted to percutaneous coronary intervention and correlation to platelet aggregation in a brazilian population receiving simple and double anti-platelet therapy - SPARC: Sequence variation on Platelet Activation in Response to Clopidogrel…
Primary sponsor Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Secondary sponsors Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Registry Registro Brasileiro de Ensaios Clinicos (ReBEC)
Recruitment status Not Recruiting
Study type Observational
Countries Brazil
Conditions Coronary atherosclerotic disease, Platelet Aggregation, Cytochrome P-450 Enzyme System;C14.280.647.250.260;G09.188.124.552.624;D08.244.453
Interventions At the index procedure, a blood sample from the patients will be obtained for DNA isolation. It will be used to identify polymorphisms in genes CYP2C19, PON1 and ABCB1. A sample size of 200 patients was calculated for a 5% confidence…
Registration date May 1, 2015
Registry page ensaiosclinicos.gov.br

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations